“CRISPR is to DNA what the Model T was to auto production. It's the first way to mass-edit DNA.”
An Interview on CRISPR and the Promise of Gene Editing
Lance Martin received a PhD at Stanford focused on genomics and machine learning. His work applying high-throughput DNA sequencing data to understand viruses and cancer disease networks has been published in leading scientific journals, including Nature and PNAS. He co-developed and patented a universal blood test for infectious disease which is now being commercialized. He is also a data science project lead at Uber on the intelligent dispatch team, which develops the science and services for pairing of riders and drivers globally.